Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Allosterism within δ Opioid-κ Opioid Receptor Heteromers in Peripheral Sensory Neurons: Regulation of κ Opioid Agonist Efficacy.

Jacobs BA, Pando MM, Jennings E, Chavera TA, Clarke WP, Berg KA.

Mol Pharmacol. 2018 Apr;93(4):376-386. doi: 10.1124/mol.117.109975. Epub 2018 Feb 7.

2.

Regulation of δ Opioid Receptor-Mediated Signaling and Antinociception in Peripheral Sensory Neurons by Arachidonic Acid-Dependent 12/15-Lipoxygenase Metabolites.

Sullivan LC, Chavera TA, Gao X, Pando MM, Berg KA.

J Pharmacol Exp Ther. 2017 Jul;362(1):200-209. doi: 10.1124/jpet.117.241604. Epub 2017 May 2. Erratum in: J Pharmacol Exp Ther. 2019 Apr;369(1):143.

3.

Studies To Examine Potential Tolerability Differences between the 5-HT2C Receptor Selective Agonists Lorcaserin and CP-809101.

Higgins GA, Silenieks LB, Patrick A, De Lannoy IAM, Fletcher PJ, Parker LA, MacLusky NJ, Sullivan LC, Chavera TA, Berg KA.

ACS Chem Neurosci. 2017 May 17;8(5):1074-1084. doi: 10.1021/acschemneuro.6b00444. Epub 2017 Mar 24.

PMID:
28338324
4.
5.

Functional selectivity of kappa opioid receptor agonists in peripheral sensory neurons.

Jamshidi RJ, Jacobs BA, Sullivan LC, Chavera TA, Saylor RM, Prisinzano TE, Clarke WP, Berg KA.

J Pharmacol Exp Ther. 2015 Nov;355(2):174-82. doi: 10.1124/jpet.115.225896. Epub 2015 Aug 21.

6.

G protein-coupled receptor 30 (GPR30) forms a plasma membrane complex with membrane-associated guanylate kinases (MAGUKs) and protein kinase A-anchoring protein 5 (AKAP5) that constitutively inhibits cAMP production.

Broselid S, Berg KA, Chavera TA, Kahn R, Clarke WP, Olde B, Leeb-Lundberg LM.

J Biol Chem. 2014 Aug 8;289(32):22117-27. doi: 10.1074/jbc.M114.566893. Epub 2014 Jun 24.

7.

Signalling profile differences: paliperidone versus risperidone.

Clarke WP, Chavera TA, Silva M, Sullivan LC, Berg KA.

Br J Pharmacol. 2013 Oct;170(3):532-45. doi: 10.1111/bph.12295.

Supplemental Content

Loading ...
Support Center